These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19539541)

  • 41. Clinical Profile and Health Disparities in a Multiethnic Cohort of Patients With Hypertrophic Cardiomyopathy.
    Butters A; Semsarian CR; Bagnall RD; Yeates L; Stafford F; Burns C; Semsarian C; Ingles J
    Circ Heart Fail; 2021 Mar; 14(3):e007537. PubMed ID: 33724884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dysrhythmias and the athlete.
    Trusty JM; Beinborn DS; Jahangir A
    AACN Clin Issues; 2004; 15(3):432-48. PubMed ID: 15475816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel mutation of the MYH7 gene in a patient with hypertrophic cardiomyopathy.
    Goel N; Huddleston CB; Fiore AC
    Turk J Pediatr; 2018; 60(3):315-318. PubMed ID: 30511546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy.
    Abchee A; Marian AJ
    J Investig Med; 1997 Apr; 45(4):191-6. PubMed ID: 9154300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multi-modality imaging in an exceptional case of aborted sudden cardiac death.
    Sonck J; Tanaka K; Czapla J; Vanderhasselt T; Kayaert P; Scott B; Sutherland G; Van Camp G
    Int J Cardiol; 2014 Feb; 171(2):e57-8. PubMed ID: 24365616
    [No Abstract]   [Full Text] [Related]  

  • 46. Early Childhood-Onset Hypertrophic Cardiomyopathy in a Family With an In-Frame
    Field E; Lopes LR; Dady K; Kaski JP
    Circ Genom Precis Med; 2022 Aug; 15(4):e003667. PubMed ID: 35862010
    [No Abstract]   [Full Text] [Related]  

  • 47. [Sudden death in hypertrophic myocardiopathy].
    Brugada J
    Rev Esp Cardiol; 1998 Dec; 51(12):991-6. PubMed ID: 9927851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypertrophic cardiomyopathy: from bedside to bench...and now back again?
    Ommen SR; Tajik AJ
    Circulation; 2001 Jul; 104(2):126-7. PubMed ID: 11447071
    [No Abstract]   [Full Text] [Related]  

  • 49. Hypertrophic cardiomyopathy and left ventricular non-compaction: Different manifestations of the same cardiomyopathy spectrum?
    Lorca R; Martín M; Gómez J; Santamarta E; Morís C; Reguero JJ; Coto E
    Int J Cardiol; 2015; 190():26-8. PubMed ID: 25912113
    [No Abstract]   [Full Text] [Related]  

  • 50. Hypertrophic cardiomyopathy: case report.
    Mukhtar AU; Ihunwo AO
    East Afr Med J; 1999 Sep; 76(9):535-6. PubMed ID: 10685328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy.
    Mathew J; Zahavich L; Lafreniere-Roula M; Wilson J; George K; Benson L; Bowdin S; Mital S
    Clin Genet; 2018 Feb; 93(2):310-319. PubMed ID: 29053178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ten common questions about hypertrophic cardiomyopathy...and misconceptions.
    Maron BJ
    Cardiol Rev; 2005; 13(2):59-60. PubMed ID: 15705254
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hypertrophic cardiomyopathy and sudden cardiac death--ICD indications in the margin of uncertainty].
    Fauchère I; Duru F
    Praxis (Bern 1994); 2009 Aug; 98(17):941-52. PubMed ID: 19711287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The role of three-dimensional speckle tracking imaging derived parameters on predicting outcome of hypertrophic cardiomyopathy patients with MYH7 mutations].
    Zhao J; Wang J; Liu LW; Zheng Y; Wang B; Li WX; Yang F; Kang N; Zuo L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):287-293. PubMed ID: 32370479
    [No Abstract]   [Full Text] [Related]  

  • 55. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
    Ramírez CD; Padrón R
    Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypertrophic cardiomyopathy.
    Maron BJ
    Lancet; 1997 Jul; 350(9071):127-33. PubMed ID: 9228976
    [No Abstract]   [Full Text] [Related]  

  • 57. Sarcomere mutations in cardiomyopathy with left ventricular hypertrabeculation.
    Dellefave LM; Pytel P; Mewborn S; Mora B; Guris DL; Fedson S; Waggoner D; Moskowitz I; McNally EM
    Circ Cardiovasc Genet; 2009 Oct; 2(5):442-9. PubMed ID: 20031619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk assessment in hypertrophic cardiomyopathy.
    Ward D
    Heart; 2009 Mar; 95(5):421; author reply 421. PubMed ID: 19218266
    [No Abstract]   [Full Text] [Related]  

  • 59. Generation of a hiPSC line ZZUNEUi007-A from a patient with hypertrophic cardiomyopathy caused by mutation in MYH7.
    Li X; Liu Y; Liu F; Wang X; Liu M; Du W; Zhao J; Wang M; Hu L; Wang C; Fu W; Dong J; Zhao X
    Stem Cell Res; 2020 Mar; 43():101699. PubMed ID: 31931472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death.
    Buja G; Miorelli M; Turrini P; Melacini P; Nava A
    Am J Cardiol; 1993 Oct; 72(12):973-6. PubMed ID: 8213559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.